Search results
What's Going With BioNTech Stock On Monday?
Benzinga· 2 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 6 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 6 days agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 7 days agoPrevnar: The pneumococcal vaccine should continue being a cash cow for the drugmaker despite potential competition from Merck's vaccine V116 in the adult...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Still No Evidence COVID-19 Vaccination Increases Cancer Risk, Despite Posts - FactCheck.org
FactCheck.org· 5 days agoIt has not been shown that COVID-19 vaccines cause or accelerate cancer. The review conclusions are mainly based on the misinterpretation of a study on ...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 6 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 5 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca ...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agoI am pleased and appreciative of how our Pfizer colleagues are executing with discipline as they focus on the patients and others we serve. This helped...
Pfizer Announces New Chief Strategy and Innovation Officer
Morningstar· 2 days agoPfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be ...
